BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8321294)

  • 1. Physicians not fazed by AZT guidelines.
    Macilwain C
    Nature; 1993 Jul; 364(6433):93. PubMed ID: 8321294
    [No Abstract]   [Full Text] [Related]  

  • 2. New guidelines issued for occupational exposures.
    AIDS Policy Law; 1998 May; 13(10):10. PubMed ID: 11365445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [AIDS drug in the correct form].
    Schenk M
    Dtsch Med Wochenschr; 1998 Sep; 123(36):A9. PubMed ID: 9765604
    [No Abstract]   [Full Text] [Related]  

  • 4. NIH panel loosens zidovudine guidelines.
    McCarthy M
    Lancet; 1993 Jul; 342(8863):104-5. PubMed ID: 8100866
    [No Abstract]   [Full Text] [Related]  

  • 5. All AIDS patients should have access to zidovudine (AZT).
    J Am Osteopath Assoc; 1990 Mar; 90(3):218. PubMed ID: 2318678
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV and pregnancy: treatment guidelines updated.
    Denison R
    WORLD; 2002 Mar; (131):4-5. PubMed ID: 11923972
    [No Abstract]   [Full Text] [Related]  

  • 7. Finding suggests AZT therapy may help prevent occupational HIV infection.
    AIDS Alert; 1995 Apr; 10(4):45-7. PubMed ID: 11362245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIH offers AZT to exposed workers.
    Booth W
    Science; 1989 Mar; 243(4895):1137. PubMed ID: 2922603
    [No Abstract]   [Full Text] [Related]  

  • 9. NIH panel identifies 11 principles for HIV therapy.
    Morey SS
    Am Fam Physician; 1998 Sep; 58(3):783-6. PubMed ID: 9750543
    [No Abstract]   [Full Text] [Related]  

  • 10. Recommendations for HIV occupational exposure.
    Paul SM; Costa SJ; Morgan D; Ziskin LZ
    N J Med; 1996 Nov; 93(11):49-54. PubMed ID: 8961746
    [No Abstract]   [Full Text] [Related]  

  • 11. Insurance company to pay for AZT.
    J Ark Med Soc; 1989 Nov; 86(6):247. PubMed ID: 2530207
    [No Abstract]   [Full Text] [Related]  

  • 12. Zidovudine (Retrovir).
    Res Initiat Treat Action; 2000 Mar; 6(1):6-7. PubMed ID: 11708188
    [No Abstract]   [Full Text] [Related]  

  • 13. Guidelines for post-exposure treatment not likely soon.
    AIDS Policy Law; 1997 Aug; 12(15):4-5. PubMed ID: 11364600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital security: 'stay current' on HIV exposure treatment guidelines.
    Hosp Secur Saf Manage; 1997 Dec; 18(8):1-3. PubMed ID: 10176068
    [No Abstract]   [Full Text] [Related]  

  • 15. AZT trials and tribulations.
    Crouch RA; Arras JD
    Hastings Cent Rep; 1998; 28(6):26-34. PubMed ID: 9868608
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA notifications. FDA approves generic AZT.
    AIDS Alert; 2007 Jul; 22(7):79. PubMed ID: 17763553
    [No Abstract]   [Full Text] [Related]  

  • 17. WHO takes major steps to make HIV treatment accessible.
    J Adv Nurs; 2002 Sep; 39(6):517-8. PubMed ID: 12365403
    [No Abstract]   [Full Text] [Related]  

  • 18. AZT patent. NIH quick off the mark.
    Gershon D
    Nature; 1991 Jul; 352(6333):268. PubMed ID: 1852193
    [No Abstract]   [Full Text] [Related]  

  • 19. To AZT or not to AZT.
    Stern A; Dickinson E
    JEMS; 1993 Oct; 18(10):29-30. PubMed ID: 10129825
    [No Abstract]   [Full Text] [Related]  

  • 20. Revised CDC guidelines underscore mother's health. Centers for Disease Control and Prevention.
    AIDS Alert; 1998 Apr; 13(4):39-42. PubMed ID: 11365140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.